Scholars Central

Conference abstractPublished 2017

Nanoprecipitation for delivery of Insulin

Authors: Antonio Ribeiro, Joana Sequeira

University of Coimbra, Portugal

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Micro- and nano-particulates made of Poly-Lactic-co-Glycolic Acid (PLGA) have been extensively studied due to their biocompatibility, biodegradability and ability to control release of drugs and have been linked to delivery of proteins. Nanoprecipitation is the most appropriate method to produce nano sizing particles for parenteral delivery without harsh conditions of temperature and agitation, making use of water miscible solvents and involving a simple set up. However, attempts to encapsulate proteins and specially insulin in PLGA nanoparticles using nanoprecipitation have revealed limited success due to a low Efficiency of Encapsulation (EE). Insulin-PLGA Nanoparticles (Ins-PLGA NPs) for parenteral administration were produced by nanoprecipitation without any co-solvent or additive to insulin, buffering the dispersant phase. NPs were freeze-dried with sorbitol and characterized for size and polydispersity (PdI) and zeta potential. Insulin extracted from NPs was assayed using HPLC and its conformation was assessed before, during and after procedure using Circular Dichroism (CD). In vitro release studies were performed to access insulin release kinetics. NPs with a mean size lower than 200 nm, a low PDI were obtained after freeze-drying and revealed physical stability after reconstitution in water. EE of NPs was greatly improved compared to previous attempts, and among formulations, the choice of a buffer with a pH close to the PI of insulin revealed a higher EE. Insulin secondary conformation was maintained during manufacture so insulin was not markedly degraded during the manufacturing process. Insulin release from NPs showed a high burst effect and a release medium pH behavior. The PLGA based NPs buffered formation occurs under mild conditions and consequently can be used as a platform for delivery of labile molecules such as most of the biotechnology-based drugs.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Pharmaceutics & Drug Delivery Research.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Pharmaceutics & Drug Delivery Research
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Antonio Ribeiro”
  • BylineArticles whose byline prints “Joana Sequeira”